Detalhe da pesquisa
1.
Cold-Adapted Viral Attenuation (CAVA): Highly Temperature Sensitive Polioviruses as Novel Vaccine Strains for a Next Generation Inactivated Poliovirus Vaccine.
PLoS Pathog
; 12(3): e1005483, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27032093
2.
Brunenders: a partially attenuated historic poliovirus type I vaccine strain.
J Gen Virol
; 96(9): 2614-2622, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018960
3.
Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.
J Virol
; 86(4): 2045-55, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156522
4.
Detection of inferred CCR5- and CXCR4-using HIV-1 variants and evolutionary intermediates using ultra-deep pyrosequencing.
PLoS Pathog
; 7(6): e1002106, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21731496
5.
Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data.
PLoS Comput Biol
; 8(11): e1002753, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23133358
6.
Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.
Mol Biol Evol
; 28(5): 1605-16, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21135151
7.
Evolution of human immunodeficiency virus type 1 in a patient with cross-reactive neutralizing activity in serum.
J Virol
; 85(16): 8443-8, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21653664
8.
High prevalence of neutralizing activity against multiple unrelated human immunodeficiency virus type 1 (HIV-1) subtype B variants in sera from HIV-1 subtype B-infected individuals: evidence for subtype-specific rather than strain-specific neutralizing activity.
J Gen Virol
; 91(Pt 1): 250-8, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19793903
9.
Synthetic virus seeds for improved vaccine safety: Genetic reconstruction of poliovirus seeds for a PER.C6 cell based inactivated poliovirus vaccine.
Vaccine
; 33(42): 5498-5502, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362098
10.
Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
Vaccine
; 33(48): 6611-6, 2015 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-26529068
11.
PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
Vaccine
; 31(5): 850-6, 2013 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23123018
12.
The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
Virology
; 422(1): 70-80, 2012 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22047989
13.
Comparison of in vivo and in vitro evolution of CCR5 to CXCR4 coreceptor use of primary human immunodeficiency virus type 1 variants.
Virology
; 412(2): 269-77, 2011 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21295814
14.
Genetic composition of replication competent clonal HIV-1 variants isolated from peripheral blood mononuclear cells (PBMC), HIV-1 proviral DNA from PBMC and HIV-1 RNA in serum in the course of HIV-1 infection.
Virology
; 405(2): 492-504, 2010 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20638697